Correlation Between Eliem Therapeutics and HCW Biologics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and HCW Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and HCW Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and HCW Biologics, you can compare the effects of market volatilities on Eliem Therapeutics and HCW Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of HCW Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and HCW Biologics.
Diversification Opportunities for Eliem Therapeutics and HCW Biologics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eliem and HCW is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and HCW Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCW Biologics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with HCW Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCW Biologics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and HCW Biologics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and HCW Biologics
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the HCW Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 7.75 times less risky than HCW Biologics. The stock trades about -0.18 of its potential returns per unit of risk. The HCW Biologics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 49.00 in HCW Biologics on August 28, 2024 and sell it today you would earn a total of 12.00 from holding HCW Biologics or generate 24.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.41% |
| Values | Daily Returns |
Eliem Therapeutics vs. HCW Biologics
Performance |
| Timeline |
| Eliem Therapeutics |
| HCW Biologics |
Eliem Therapeutics and HCW Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and HCW Biologics
The main advantage of trading using opposite Eliem Therapeutics and HCW Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, HCW Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCW Biologics will offset losses from the drop in HCW Biologics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |